Cite
HARVARD Citation
Boucaud‐Maitre, D. et al. (2016). In response to Alqahtani et al. (2015 Jul; 24(7):709–15): suggesting an international regulatory harmonization for priority review drugs need further investigations. Pharmacoepidemiology and drug safety. 25 (6), pp. 743-744. [Online].